134 related articles for article (PubMed ID: 8444056)
1. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
Nahata MC; Kohlbrenner VM; Barson WJ
Chemotherapy; 1993; 39(1):1-5. PubMed ID: 8444056
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacologic aspects of cefixime in dogs.
Lavy E; Ziv G; Aroch I; Glickman A
Am J Vet Res; 1995 May; 56(5):633-8. PubMed ID: 7661460
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Mamzoridi K; Kasteridou N; Peonides A; Niopas I
Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.
Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ
Chemotherapy; 1990; 36(2):103-8. PubMed ID: 2311439
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Kees F; Naber KG
Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
[TBL] [Abstract][Full Text] [Related]
7. Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
Moorthi K; Fleckenstein G; Nies B
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):287-90. PubMed ID: 2374476
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and clinical effects of cefixime in pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita S; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Nagayama K
Jpn J Antibiot; 1986 Apr; 39(4):1177-200. PubMed ID: 3761546
[TBL] [Abstract][Full Text] [Related]
9. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
Stone JW; Linong G; Andrews JM; Wise R
J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies on cefixime in pediatrics].
Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M
Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
Nahata MC; Durrell DE; Barson WJ
Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
[TBL] [Abstract][Full Text] [Related]
12. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants.
Chen XK; Shi HY; Leroux S; Xu HY; Zhou Y; Zheng Y; Huang X; Li Y; Jacqz-Aigrain E; Zhao W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437625
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.
Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ
Chemotherapy; 1990; 36(2):98-102. PubMed ID: 2311446
[TBL] [Abstract][Full Text] [Related]
14. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.
Myrianthefs P; Markantonis SL; Vlachos K; Anagnostaki M; Boutzouka E; Panidis D; Baltopoulos G
Antimicrob Agents Chemother; 2006 Dec; 50(12):3971-6. PubMed ID: 16982782
[TBL] [Abstract][Full Text] [Related]
15. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.
Chadwick EG; Yogev R; Shulman ST; Weinfeld RE; Patel IH
J Pediatr; 1983 Jan; 102(1):134-7. PubMed ID: 6294263
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis.
Blumer JL; Aronoff SC; Myers CM; O'Brien CA; Klinger JD; Reed MD
Dev Pharmacol Ther; 1985; 8(4):219-31. PubMed ID: 3896704
[TBL] [Abstract][Full Text] [Related]
17. Cefixime penetration in human renal parenchyma.
Leroy A; Oser B; Grise P; Humbert G
Antimicrob Agents Chemother; 1995 Jun; 39(6):1240-2. PubMed ID: 7574508
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of three cefixime formulations.
Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of cefixime in man.
Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefixime in the young and elderly.
Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
